Korean Journal of Ophthalmology10.3341/kjo.2019.0081202034111Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration PatientsSe Young Kim, Myung Hun Yoon, Hee Seung Chin,,
Ophthalmologica10.1159/00044538820162354225-232Arteriosclerotic Changes after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Patients with Exudative Age-Related Macular DegenerationTomoaki Shiba, Mao Takahashi, Izumi Yoshida, Hikari Taniguchi, Tadashi Matsumoto, Yuichi Hori,,
Ophthalmologica10.1159/00047943720172384217-225Different Clinical Courses on Long-Term Follow-Up of Age-Related Macular Degeneration Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsOded Sagiv, Ofira Zloto, Iris Moroz, Joseph Moisseiev
Ophthalmology Retina10.1016/j.oret.2018.04.025201827643-644Real-World Papers, Prophylaxis for Intravitreal Injections, Fluorescein Angiography and Neovascular Age-Related Macular Degeneration, and Anti–Vascular Endothelial Growth Factor SafetyAndrew P. Schachat,
Clinical Ophthalmology10.2147/opth.s3167420121073Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degenerationShigeki Machida, Nishimura, Harada, Daijiro Kurosaka
Ophthalmology Retina10.1016/j.oret.2018.05.00520182121188-1195Racial Differences in Age-Related Macular Degeneration and Associated Anti–Vascular Endothelial Growth Factor Intravitreal Injections among Medicare BeneficiariesMichael A. Mahr, David O. Hodge, Jay C. Erie,
Age and Ageing10.1093/ageing/afab2622021511Ten-year mortality and long-term visual acuity outcomes in patients with exudative age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor injectionsSu Ling Young, Martin J Anderson, Shyamanga Borooah, Ana-Maria Armbrecht, Peter D Cackett,
American Journal of Ophthalmology10.1016/j.ajo.2016.04.003201616710-17Retinal Ganglion Cell Layer Change in Patients Treated With Anti–Vascular Endothelial Growth Factor for Neovascular Age-related Macular DegenerationMarco Beck, Marion R. Munk, Andreas Ebneter, Sebastian Wolf, Martin S. Zinkernagel,
Ophthalmology Retina10.1016/j.oret.2020.05.00520204111047-1053Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti–Vascular Endothelial Growth Factor InjectionsFelix F. Kung, Matthew R. Starr, Yvonne T. Bui, Camilo A. Mejia, Sophie J. Bakri,
Taiwan Journal of Ophthalmology10.1016/j.tjo.2013.11.00220144128-32Intraocular pressure changes after repeated intravitreal antivascular endothelial growth factor injections in patients with neovascular age-related macular degeneration with or without glaucomaTze-Yi Chan, Cheng-Kuo Cheng,